15. Blade J, Samson D, Reece D, et al.: Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102:1115-1123, 1998.

16. Corradini P, Voena C, Tarella C, et al.: Molecular and clinical remissions in multiple myeloma: role of autolo-gous and allogeneic transplantation of hematopoietic cells. J Clin Oncol 17:208-215, 1999.

17. Ladetto M, Donovan JW, Harig S, et al.: Real-time poly-merase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma. Biol Blood Marrow Transplant 6:241-253, 2000.

18. Gahrton G, Tura S, Flesch M, et al.: Stem cell transplantation in multiple myeloma: report from the European Cooperative Group for Stem cell Transplantation. Blood 69:1262, 1987.

19. Kulkarni S, Powles RL, Treleaven JG, et al.: Impact of previous high-dose therapy on outcome after allograft-ing for multiple myeloma. Stem cell Transplant 23: 675-680, 1999.

20. Bensinger WI, Buckner CD, Anasetti C, et al.: Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome. Blood 88:2787-2793,

0 0

Post a comment